COCCO, LUCIO ILDEBRANDO MARIA

COCCO, LUCIO ILDEBRANDO MARIA  

Mostra records
Risultati 1 - 12 di 12 (tempo di esecuzione: 0.02 secondi).
Titolo Data di pubblicazione Autore(i) File
A role of PI-PLCb1 in G1/S transition in human erythroleukemia k562 cells 1-gen-2012 Poli, Alessandro; Faenza, Irene; Matteucci, Alessandro; Chiarini, Francesca; Cocco, LUCIO ILDEBRANDO
Effect of Erythropoietin Treatment on Lipid Signalling Pathways in Low-Risk MDS Patients 1-gen-2009 Follo, MATILDE YUNG; Mongiorgi, Sara; Clissa, Cristina; Chiarini, Francesca; Paolini, Stefania; Baccarani, Michele; Martinelli, Giovanni; Manzoli, Lucia; Martelli, ALBERTO MARIA; Finelli, Carlo; Cocco, LUCIO ILDEBRANDO
Effect of Lenalidomide Treatment on Lipid Signalling Pathways in Low-Risk MDS Patients 1-gen-2011 Follo, MATILDE YUNG; Clissa, Cristina; Mongiorgi, Sara; Chiarini, Francesca; Baccarani, Michele; Martinelli, Giovanni; Manzoli, Lucia; Martelli, ALBERTO MARIA; Finelli, Carlo; Cocco, LUCIO ILDEBRANDO
Involvement of nuclear PLC{beta}1 in lamin B1 phosphorylation and G2/M cell cycle progression 1-gen-2009 Fiume, Roberta; Ramazzotti, Giulia; Teti, Gabriella; Chiarini, Francesca; Faenza, Irene; Mazzotti, Giovanni; Billi, ANNA MARIA; Cocco, LUCIO ILDEBRANDO
Preclinical testing of the Akt inhibitor triciribine in T-cell acute lymphoblastic leukemia 1-gen-2011 Evangelisti, Camilla; Ricci, Francesca; Tazzari, Pierluigi; Chiarini, Francesca; Battistelli, Michela; Falcieri, Elisabetta; Ognibene, Andrea; Pagliaro, Pasqualepaolo; Cocco, Lucio; Mccubrey, James A; Martelli, Alberto M
Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor (2S)-1-(1H-Indol-3-yl)-3-[5-(3-methyl-2H-indazol-5-yl)pyridin-3-yl]oxypropan2-ami ne (A443654) in T-cell acute lymphoblastic leukemia 1-gen-2008 Fala', Federica; Blalock, Wl; Tazzari, Pl; Cappellini, A; Chiarini, Francesca; Martinelli, Giovanni; Tafuri, A; Mccubrey, Ja; Cocco, LUCIO ILDEBRANDO; Martelli, ALBERTO MARIA
Reduction of phosphoinositide-phospholipase C beta1 methylation predicts the responsiveness to azacitidine in high-risk MDS 1-gen-2009 Follo, MATILDE YUNG; Finelli, Carlo; Mongiorgi, Sara; Clissa, C; Bosi, C; Testoni, Nicoletta; Chiarini, Francesca; Ramazzotti, Giulia; Baccarani, Michele; Martelli, ALBERTO MARIA; Manzoli, Lucia; Martinelli, Giovanni; Cocco, LUCIO ILDEBRANDO
Synergistic induction of PI-PLCbeta1 signaling by azacitidine and valproic acid in high-risk myelodysplastic syndromes 1-gen-2011 Follo, MATILDE YUNG; Finelli, Carlo; Mongiorgi, Sara; Clissa, C; Chiarini, Francesca; Ramazzotti, Giulia; Paolini, Stefania; Martinelli, Giovanni; Martelli, ALBERTO MARIA; Cocco, LUCIO ILDEBRANDO
Synergistic proapoptotic activity of recombinant TRAIL plus the Akt inhibitor perifosine in acute myeloid leukemia cells 1-gen-2008 Tazzari, P. L.; Tabellini, Giovanna; Ricci, F.; Papa, Veronica; Bortul, R.; Chiarini, Francesca; Evangelisti, Camilla; Martinelli, Giovanni; Bontadini, A.; Cocco, LUCIO ILDEBRANDO; Mccubrey, J. A.; Martelli, ALBERTO MARIA
Targeting the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin module for acute myelogenous leukemia therapy: from bench to bedside 1-gen-2007 Martelli, ALBERTO MARIA; Tazzari, Pl; Evangelisti, Camilla; Chiarini, Francesca; Blalock, Wl; Billi, ANNA MARIA; Manzoli, Lucia; Mccubrey, Ja; Cocco, LUCIO ILDEBRANDO
The Akt/mammalian target of rapamycin signal transduction pathway is activated in high-risk myelodysplastic syndromes and influences cell survival and proliferation 1-gen-2007 Follo, MATILDE YUNG; Mongiorgi, Sara; Bosi, Costanza; Cappellini, Alessandra; Finelli, Carlo; Chiarini, Francesca; Papa, Veronica; Libra, Massimo; Martinelli, Giovanni; Cocco, LUCIO ILDEBRANDO; Martelli, ALBERTO MARIA
Toxicity of antimony trioxide nanoparticles on human hematopoietic progenitor cells and comparison to cell lines 1-gen-2009 Bregoli, Lisa; Chiarini, Francesca; Gambarelli, A; Sighinolfi, G; Gatti, Am; Santi, Patrizia; Martelli, ALBERTO MARIA; Cocco, LUCIO ILDEBRANDO